BETHLEHEM, Pa., Sept. 14, 2022 (GLOBE NEWSWIRE) — OraSure Technologies, Inc. (NASDAQ:OSUR), a global leader in point-of-care and home diagnostic testing and sample collection technologies, announced today a new collaboration between Diversigen, Inc., a subsidiary of OraSure Technologies, and Mars Petcare, which will help researchers better understand pet health. As part of the MARS PETCARE BIOBANK™ project, Diversigen will sequence microbiome samples from cats and dogs of all breeds and breed makeups in efforts to improve pet care.
Despite Seeing Accelerated 2023 Growth, This Analyst Cut Penumbra’s Price Target – Here’s Why
Penumbra Inc (NYSE:PEN) reported Q1 sales that beat Street expectations, driven by Vascular upside, and reiterated its 2022 revenue guidance. Wells…
